What excites me about stem cell and gene therapies
is the massive potential that it has and the curative aspect of it so when you look at
traditional ways of treatment you were treating symptoms whereas now you’re in this exciting
field that can basically cure you of your disease and then you move on with a normal
life it just has so many options to help someone the masters in manufacturing and commercialisation
of stem cell and gene therapies is a new one-year programme established at UCLin the department
of biochemical engineering which focuses on developing the next generation of engineers,
scientists and business professionals to develop, manufacture and commercialise advanced therapies,
particularly stem cells and gene therapies we have a steering committee of industrial
experts who are going to going to give us their experience of the industry in our teaching
and show how they work and that’s going to be invaluable for any student who is looking
to get into the sector and I’ve been teaching for ten years plus in higher education and
I’ve never had that before it’s a fantatsic opportunity for students because we can put
in information that the experts in the industry want to impart themselves this is a unique
opportunity for students who want to learn about science and engineering manufacturing
and the business side of delivering products to pateints the steering committee is really
important because it’s comprised both of the academic leaders and also industry experts
like myself and together what we’re going to do is is to craft this course to make sure
it’s really relevant with the most contemporary knowledge that’s available to the students
I’ve been fortunate enough to be in the cell and gene therapy space for quite a long time
starting out as a clinician and then working to develop therapies for patients and through
that time I’ve noticed how amazing it is to really make a very big difference to patients
lifes and I’d really like to share that with the new people who are coming onto lead the
therapies of the future but more importantly I want to learn from them because it’s only
with their ideas that we’ll really move this area forward this is a great opportunitiy
for the UK as a country but the secor as a whole gobally and it has a specific need for
skill right across the skillset for what is required in the industry the good thing about
this programme is that we’re not getting the students ready for one kind of a job on the
contrary we will make the students aware that they have different opporunities for example
we’ll teach them research in the lab they’re going to be doing cost analysis and commercialisation
so when they finish they can go to a company and within the company they can work in differenet
sectors like legislation bioprocessing analytics pre-clinical and even commercialisation and
not only that we’re going to make them explore more research so if they want to go and do
a PhD in collaboration with a company they can do an EngD too there is a massive impact
of industry into degree there is a massive connection which as a master’s student that’s
what you want to have you want to know where you’ll be worrking in the future you want
to see what they want what they need what their challenges are and how you can learn
about how to solve them this programme allows us to understand and appreciate all the factors
which will go into manufacturing and developping these advanced therapies so that includes
ethics regulations and initialisation manufacturing and commercialisation essentially optimising
the manufacturing process keeping in mind all these factors in order to create an advanced
therapy for the patient at an affordable price for the healthcare system for society as a
whole we’re looking for students who are pro-active and want to make a change students that realise
we are currently at a tipping point in the global healthcare industry we need new therapeutic
modalities to address the chronic age related conditions we’re now facing we want to empower
enhance and enable two types of future complementary leaders scientiric and manufacturing leaders
and business and technology leaders who can propel this industry forward and address some
of the key challenges that we face in getting these therapies to patients that need them